Literature DB >> 5032448

Gout in a New England town. A prevalence study in Sudbury, Massachusetts.

J B O'Sullivan.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 5032448      PMCID: PMC1005891          DOI: 10.1136/ard.31.3.166

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  COMPARISON OF A COLORIMETRIC (AUTOMATED) WITH AN ENZYMATIC (MANUAL) URIC ACID PROCEDURE.

Authors:  J B O'SULLIVAN; J O FRANCIS; N KANTOR
Journal:  Clin Chem       Date:  1965-03       Impact factor: 8.327

2.  Gout and hyperuricaemia in rural and urban populations.

Authors:  A J POPERT; J V HEWITT
Journal:  Ann Rheum Dis       Date:  1962-06       Impact factor: 19.103

3.  Rheumatoid arthritis in a New England town. A prevalence study in Sudbury, Massachusetts.

Authors:  E S Cathcart; J B O'Sullivan
Journal:  N Engl J Med       Date:  1970-02-19       Impact factor: 91.245

4.  Observations on the distribution of serum uric acid levels in participants of the Tecumseh, Michigan, Community Health Studies. A comparison of results of one method used at two different times and of two methods used simultaneously.

Authors:  H J Dodge; W M Mikkelsen
Journal:  J Chronic Dis       Date:  1970-09

5.  Epidemiology of gout and hyperuricemia. A long-term population study.

Authors:  A P Hall; P E Barry; T R Dawber; P M McNamara
Journal:  Am J Med       Date:  1967-01       Impact factor: 4.965

  5 in total
  18 in total

Review 1.  The epidemiology of uric acid and fructose.

Authors:  Young Hee Rho; Yanyan Zhu; Hyon K Choi
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

Review 2.  Recent advances in the epidemiology of gout.

Authors:  Kenneth G Saag; Ted R Mikuls
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

Review 3.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 4.  Determinants of the prevalence of gout in the general population: a systematic review and meta-regression.

Authors:  José M A Wijnands; Wolfgang Viechtbauer; Kristof Thevissen; Ilja C W Arts; Pieter C Dagnelie; Coen D A Stehouwer; Sjef van der Linden; Annelies Boonen
Journal:  Eur J Epidemiol       Date:  2014-07-27       Impact factor: 8.082

Review 5.  New classification criteria for gout: a framework for progress.

Authors:  Nicola Dalbeth; Jaap Fransen; Tim L Jansen; Tuhina Neogi; H Ralph Schumacher; William J Taylor
Journal:  Rheumatology (Oxford)       Date:  2013-04-22       Impact factor: 7.580

6.  Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts.

Authors:  Mara A McAdams; Janet W Maynard; Alan N Baer; Anna Köttgen; Sandra Clipp; Josef Coresh; Allan C Gelber
Journal:  J Rheumatol       Date:  2010-12-01       Impact factor: 4.666

7.  Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands.

Authors:  M M Steven
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 8.  Management of acute and chronic gouty arthritis: present state-of-the-art.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.

Authors:  Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-01

10.  Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010.

Authors:  Stephen P Juraschek; Lara C Kovell; Edgar R Miller; Allan C Gelber
Journal:  Semin Arthritis Rheum       Date:  2013-01-09       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.